JP2023541040A5 - - Google Patents
Info
- Publication number
- JP2023541040A5 JP2023541040A5 JP2023515741A JP2023515741A JP2023541040A5 JP 2023541040 A5 JP2023541040 A5 JP 2023541040A5 JP 2023515741 A JP2023515741 A JP 2023515741A JP 2023515741 A JP2023515741 A JP 2023515741A JP 2023541040 A5 JP2023541040 A5 JP 2023541040A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- formula
- alkyl
- compound
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063077329P | 2020-09-11 | 2020-09-11 | |
| US63/077,329 | 2020-09-11 | ||
| US202163148823P | 2021-02-12 | 2021-02-12 | |
| US63/148,823 | 2021-02-12 | ||
| PCT/US2021/049362 WO2022055926A1 (en) | 2020-09-11 | 2021-09-08 | Compositions and methods for treating muscular dystrophies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023541040A JP2023541040A (ja) | 2023-09-27 |
| JP2023541040A5 true JP2023541040A5 (cg-RX-API-DMAC7.html) | 2024-09-17 |
Family
ID=80630037
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023515741A Pending JP2023541040A (ja) | 2020-09-11 | 2021-09-08 | 筋ジストロフィーを処置するための組成物及び方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230348394A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4211131A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023541040A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230067637A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021341960A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3192071A1 (cg-RX-API-DMAC7.html) |
| CL (1) | CL2023000698A1 (cg-RX-API-DMAC7.html) |
| CO (1) | CO2023004447A2 (cg-RX-API-DMAC7.html) |
| IL (1) | IL301122A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023002947A (cg-RX-API-DMAC7.html) |
| SA (1) | SA523442922B1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022055926A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022129120A1 (en) | 2020-12-17 | 2022-06-23 | F. Hoffmann-La Roche Ag | Anti-hla-g antibodies and use thereof |
| WO2024229205A1 (en) * | 2023-05-03 | 2024-11-07 | The Regents Of The University Of California | Small molecule therapy for duchenne muscular dystrophy |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3514490B2 (ja) * | 1992-08-21 | 2004-03-31 | 杏林製薬株式会社 | トリフルオロメチルピロロインドールカルボン酸エステル誘導体及びその製造方法 |
| CA2881078C (en) * | 2004-06-24 | 2018-10-02 | Vertex Pharmaceuticals Incorporated | Modulators of atp-binding cassette transporters |
| WO2007008541A2 (en) * | 2005-07-08 | 2007-01-18 | Kalypsys, Inc. | Cellular cholesterol absorption modifiers |
| WO2008059214A1 (en) * | 2006-11-13 | 2008-05-22 | Astrazeneca Ab | Bisamlde derivatives and use thereof as fatty acid synthase inhibitors |
| GB0715939D0 (en) * | 2007-08-15 | 2007-09-26 | Vastox Plc | Method of treatment of duchenne muscular dystrophy |
| US20120184548A1 (en) * | 2011-01-19 | 2012-07-19 | Romyr Dominique | Carboxylic acid aryl amides |
| AU2016370779B2 (en) * | 2015-12-17 | 2019-07-25 | Astex Therapeutics Limited | Quinoline-3-carboxamides as H-PGDS inhibitors |
| RU2019133662A (ru) * | 2017-03-24 | 2021-04-26 | Тайсо Фармасьютикал Ко., Лтд. | Производное 2(1h)-хинолинона |
| WO2019084499A1 (en) * | 2017-10-27 | 2019-05-02 | Genea Biocells USA (Holdings), Inc. | INHIBITORS OF DUX4 INDUCTION FOR REGULATION OF MUSCLE FUNCTION |
| WO2019236677A1 (en) * | 2018-06-05 | 2019-12-12 | The Regents Of The University Of California | Methods for treating muscular dystrophies |
-
2021
- 2021-09-08 MX MX2023002947A patent/MX2023002947A/es unknown
- 2021-09-08 KR KR1020237011841A patent/KR20230067637A/ko active Pending
- 2021-09-08 US US18/025,747 patent/US20230348394A1/en active Pending
- 2021-09-08 AU AU2021341960A patent/AU2021341960A1/en active Pending
- 2021-09-08 WO PCT/US2021/049362 patent/WO2022055926A1/en not_active Ceased
- 2021-09-08 JP JP2023515741A patent/JP2023541040A/ja active Pending
- 2021-09-08 EP EP21867476.0A patent/EP4211131A4/en active Pending
- 2021-09-08 IL IL301122A patent/IL301122A/en unknown
- 2021-09-08 CA CA3192071A patent/CA3192071A1/en active Pending
-
2023
- 2023-03-10 CL CL2023000698A patent/CL2023000698A1/es unknown
- 2023-03-12 SA SA523442922A patent/SA523442922B1/ar unknown
- 2023-04-11 CO CONC2023/0004447A patent/CO2023004447A2/es unknown